Patents matching “s1”

US 8859727

Bioactive FUS1 peptides and nanoparticle-polypeptide complexes

The Board of Regents of the University of Texas System · Granted Oct 14, 2014 · Expires Oct 9, 2034

US 8735066

Tumor suppressor designated TS10Q23.3

The Board of Regents of the University of Texas System · Granted May 27, 2014 · Expires May 22, 2034

US 8338366

Bioactive FUS1 peptides and nanoparticle-polypeptide complexes

The Board of Regents of the University of Texas System · Granted Dec 25, 2012 · Expires Dec 20, 2032

EP 2511275

Neuartige Piperidinyl-monocarboxylsäuren als S1P1 Rezeptoragonisten

BIOPROJET SOC CIV [FR] · Granted Oct 17, 2012 · Expires Oct 12, 2032

US 8252807

Methods of inhibiting the interaction between S100 and the receptor for advanced glycation end-products

The Board of Regents of the University of Texas System · Granted Aug 28, 2012 · Expires Aug 23, 2032

US 7732576

Tumor suppressor designated TS10Q23.3

The Board of Regents of the University of Texas System · Granted Jun 8, 2010 · Expires Jun 3, 2030

EP 2014653

Neue Dicarbonsäurederivate als S1P1 Rezeptor Agonisten

BIOPROJET SOC CIV [FR] · Granted Jan 14, 2009 · Expires Jan 9, 2029

US 7217795

Tumor suppressor designated TS10q23.3

The Board of Regents of the University of Texas System · Granted May 15, 2007 · Expires May 10, 2027

US 7214519

Screening method for identifying heme independent modulators of soluble guanylyl cyclase (sGC) activity using αβCys105 mutant sGC

The Board of Regents of the University of Texas System · Granted May 8, 2007 · Expires May 3, 2027

US 6482795

Tumor suppressor designated TS10q23.3

The Board of Regents of the University of Texas System · Granted Nov 19, 2002 · Expires Nov 14, 2022

US 6262242

Tumor suppressor designated TS10Q23.3

The Board of Regents of the University of Texas System · Granted Jul 17, 2001 · Expires Jul 12, 2021